News Release: Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors

2/7/2018, 6:00 PM (Source: GlobeNewswire)

 Changes to Essilor International
(Compagnie Générale d'Optique) Board of Directors

PDF Version of the news release

Charenton-le-Pont, France (February 7, 2018 - 6:00 p.m.) - The Board of Directors of Essilor International (Compagnie Générale d'Optique) ("Essilor") has announced two changes in its composition:

  • Henrietta Fore has announced her resignation from the Essilor Board of Directors after being appointed Executive Director of UNICEF on January 1, 2018.

The members of the Board of Directors congratulated Mrs. Fore on her new appointment and thanked her warmly for her very important contribution to the Board's work over the past two years.

  • Yi He, Director representing the employee shareholders through the Valoptec Association, has also announced that he will resign from the Essilor Board of Directors following the end of his term as a Board director of the Valoptec Association.

Given that the combination with Luxottica is under way, the Essilor Board of Directors did not feel this was an appropriate time to appoint two new members to succeed them.

As Henrietta Fore had been nominated to the Board of Directors of the future EssilorLuxottica, a new female director will be nominated in the near future and that appointment will be submitted for approval to Essilor's next General Shareholders' Meeting.

  

About Essilor
Essilor International (Compagnie Générale d'Optique) ("Essilor") is the world's leading ophthalmic optics company. Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, EyezenTM, Xperio®, Foster Grant®, BolonTM and Costa®. Essilor also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs approximately 64,000 people worldwide. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world (as of December 31, 2016). For more information, please visit www.essilor.com.
The Essilor share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. 
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

CONTACTS

Investor Relations
Véronique Gillet - Sébastien Leroy
Ariel Bauer - Alex Kleban
Tel: +33 (0)1 49 77 42 16
Corporate Communications
Laura Viscovich

 

Tel: +33 (0)1 49 77 45 02
Media Relations
Maïlis Thiercelin

 

Tel: +33 (0)1 49 77 45 02



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Essilor International via Globenewswire

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.